{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:49:37Z","timestamp":1782877777031,"version":"3.54.5"},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,3,15]]},"DOI":"10.18632\/oncotarget.6970","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T14:07:49Z","timestamp":1453385269000},"page":"12447-12463","source":"Crossref","is-referenced-by-count":33,"title":["PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Winson S.","family":"Ho","sequence":"first","affiliation":[{"name":"Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Maric","sequence":"additional","affiliation":[{"name":"NINDS Flow Cytometry Core Facility, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Amable","sequence":"additional","affiliation":[{"name":"National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Hall","sequence":"additional","affiliation":[{"name":"National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald M.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhik","family":"Ray-Chaudhury","sequence":"additional","affiliation":[{"name":"Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Lizak","sequence":"additional","affiliation":[{"name":"In Vivo NMR Center, National Institute of Neurological Disorder and Stroke, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"Vera","sequence":"additional","affiliation":[{"name":"School of Medicine, Tulane University, New Orleans, LA 70112"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Aaron","family":"Robison","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA 90027"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Heiss","sequence":"additional","affiliation":[{"name":"Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,1,21]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009","volume":"14","author":"Kruchko","year":"2012","journal-title":"Neuro Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/neuonc\/nos267","article-title":"Survival, secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961","volume":"15","author":"Gajjar","year":"2013","journal-title":"Neuro-oncology"},{"key":"3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00401-013-1213-7","article-title":"Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group","volume":"127","author":"Cole","year":"2014","journal-title":"Acta Neuropathol"},{"key":"4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ctrv.2008.09.002","article-title":"Pediatric medulloblastoma: toxicity of current treatment and potential role of protontherapy","volume":"35","author":"Orecchia","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-009-9927-z","article-title":"From childhood to adulthood: long-term outcome of medulloblastoma patients. The Institut Curie experience (1980-2000)","volume":"95","author":"Doz","year":"2009","journal-title":"J Neurooncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/neuonc\/nop031","article-title":"High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma","volume":"12","author":"Finlay","year":"2010","journal-title":"Neuro Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00401-012-0958-8","article-title":"Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas","volume":"123","author":"von Bueren","year":"2012","journal-title":"Acta Neuropathol"},{"key":"8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.spen.2014.12.010","article-title":"Medulloblastoma: toward biologically based management","volume":"22","author":"Packer","year":"2015","journal-title":"Semin Pediatr Neurol"},{"key":"9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/15384047.2015.1040961","article-title":"LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential","volume":"16","author":"Zhuang","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"10","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/S1470-2045(12)70558-2","article-title":"Protein phosphatase 2A: a target for anticancer therapy","volume":"14","author":"Neviani","year":"2013","journal-title":"Lancet Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2007.06.034","article-title":"PP2A: unveiling a reluctant tumor suppressor","volume":"130","author":"Mumby","year":"2007","journal-title":"Cell"},{"key":"12","doi-asserted-by":"crossref","first-page":"11697","DOI":"10.1073\/pnas.0905930106","article-title":"Inhibition of serine\/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms","volume":"106","author":"Zhuang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13","unstructured":"Vincent Chung, Fadi, Carlos, Donald. 2015. Phase I Study of LB-100 With Docetaxel in Solid Tumors."},{"key":"14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1535-7163.MCT-14-0496","article-title":"The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity","volume":"14","author":"Gottesman","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"15","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1080\/15384101.2015.1041693","article-title":"Inhibition of protein phosphatase 2A with the small molecule LB100 overcomes cell cycle arrest in osteosarcoma after cisplatin treatment","volume":"14","author":"Zhou","year":"2015","journal-title":"Cell Cycle"},{"key":"16","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1158\/1535-7163.MCT-13-0800","article-title":"Inhibition of protein phosphatase 2A enhances cytotoxicity and accessibility of chemotherapeutic drugs to hepatocellular carcinomas","volume":"13","author":"Liang","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"17","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1158\/1535-7163.MCT-14-0614","article-title":"Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in Glioblastoma","volume":"14","author":"Chen","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"18","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.18632\/oncotarget.2258","article-title":"Inhibition of protein phosphatase 2A with a small molecule LB100 radiosensitizes nasopharyngeal carcinoma xenografts by inducing mitotic catastrophe and blocking DNA damage repair","volume":"5","author":"Zeng","year":"2014","journal-title":"Oncotarget"},{"key":"19","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1158\/1078-0432.CCR-13-0788","article-title":"Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C\/CDK1 and homologous recombination repair","volume":"19","author":"Morgan","year":"2013","journal-title":"Clin Cancer Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Jove","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"21","first-page":"2381","article-title":"Variations in the levels of the JAK\/STAT and ShcA proteins in human brain tumors","volume":"18","author":"Govoni","year":"1998","journal-title":"Anticancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/sj.onc.1205263","article-title":"Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2)","volume":"21","author":"Schaefer","year":"2002","journal-title":"Oncogene"},{"key":"23","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1158\/1535-7163.MCT-08-0138","article-title":"Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas","volume":"7","author":"Jove","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"24","doi-asserted-by":"publisher","first-page":"7149","DOI":"10.18632\/oncotarget.2240","article-title":"In comparative analysis of multi-kinase inhibitors for targeted medulloblastoma therapy pazopanib exhibits promisingandefficacy","volume":"5","author":"Dilloo","year":"2014","journal-title":"Oncotarget"},{"key":"25","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1074\/jbc.M114.616748","article-title":"A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells","volume":"290","author":"Lin","year":"2015","journal-title":"J Biol Chem"},{"key":"26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1541-7786.MCR-09-0220","article-title":"Sunitinib induces apoptosis and growth arrest of medulloblastoma tumor cells by inhibiting STAT3 and AKT signaling pathways","volume":"8","author":"Yu","year":"2010","journal-title":"Mol Cancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00381-011-1672-x","article-title":"Inhibition of phosphorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells","volume":"28","author":"Liu","year":"2012","journal-title":"Childs Nerv Syst"},{"key":"28","doi-asserted-by":"crossref","first-page":"11013","DOI":"10.3390\/ijms150611013","article-title":"Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells","volume":"15","author":"Ma","year":"2014","journal-title":"Int J Mol Sci"},{"key":"29","doi-asserted-by":"crossref","first-page":"10620","DOI":"10.1073\/pnas.96.19.10620","article-title":"Inhibition of protein phosphatase 2A induces serine\/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3","volume":"96","author":"Odum","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11010-005-3089-x","article-title":"Protein phosphatase type 2A, PP2A, is involved in degradation of gp130","volume":"269","author":"Kikuchi","year":"2005","journal-title":"Mol Cell Biochem"},{"key":"31","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.cellsig.2014.04.003","article-title":"Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells","volume":"26","author":"Ghosh","year":"2014","journal-title":"Cell Signal"},{"key":"32","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.cell.2013.01.036","article-title":"Targeting placental growth factor\/neuropilin 1 pathway inhibits growth and spread of medulloblastoma","volume":"152","author":"Schmidt","year":"2013","journal-title":"Cell"},{"key":"33","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1158\/0008-5472.CAN-12-4331","article-title":"Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children","volume":"73","author":"Bouffet","year":"2013","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.18632\/oncotarget.2737","article-title":"Cisplatin-selected resistance is associated with increased motility and stem-like properties via activation of STAT3\/Snail axis in atypical teratoid\/rhabdoid tumor cells","volume":"6","author":"Ma","year":"2015","journal-title":"Oncotarget"},{"key":"35","doi-asserted-by":"crossref","first-page":"30880","DOI":"10.1074\/jbc.R114.609248","article-title":"Multidrug resistance protein 1 (MRP1, ABCC1), a \"multitasking\" ATP-binding cassette (ABC) transporter","volume":"289","author":"Cole","year":"2014","journal-title":"J Biol Chem"},{"key":"36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2990.2005.00664.x","article-title":"Survivin is a negative prognostic marker in medulloblastoma","volume":"31","author":"Popovic","year":"2005","journal-title":"Neuropathol Appl Neurobiol"},{"key":"37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature11327","article-title":"Subgroup-specific structural variation across 1,000 medulloblastoma genomes","volume":"488","author":"Marshall","year":"2012","journal-title":"Nature"},{"key":"38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13046-014-0062-0","article-title":"Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention","volume":"33","author":"Bonavida","year":"2014","journal-title":"J Exp Clin Cancer Res"},{"key":"39","article-title":"Medulloblastoma","author":"De Braganca","year":"2015","journal-title":"J Child Neurol"},{"key":"40","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1124\/pr.111.005637","article-title":"Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes","volume":"64","author":"Gottesman","year":"2012","journal-title":"Pharmacol Rev"},{"key":"41","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1158\/0008-5472.CAN-14-0247","article-title":"Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes","volume":"74","author":"Gottesman","year":"2014","journal-title":"Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T17:54:34Z","timestamp":1589219674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,21]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,3,15]]}},"alternative-id":["6970","26799670"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6970","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,21]]}}}